ISPE would like to gratefully acknowledge the contribution of the following supporters:
Jiangsu Hengrui Medicine
Jiangsu Hengrui Medicine Co., Ltd., established in 1970 and headquartered in
Lianyungang, Jiangsu Province, is not only the front-runner in China’s innovative medicine, but also a well-known R&D center of antineoplastics and surgical medicine in China. Taking the slogan that “Science & Technology for a Better Life”, Hengrui Medicine is dedicated to researching, developing, and promoting innovative medicine with high quality. We aim to help doctors solve clinical problems, help patients be cured, and help improve the standard of health for all humanity.
For more than a century, MSD has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases. Today, MSD continues to be at the forefront of research to deliver innovative health solutions and advance the prevention and treatment of diseases that threaten people and animals around the world.
Mission in China Pfizer began its business operations in China in the 1980’s and is now the leading multinational biopharmaceutical company in the country, with a presence in over 300 cities nationwide and a total staff more than 11,000. With the mission of Working Together for a Healthier China, we strive to “Become an Essential Part of China Healthcare System” and are committed to actively participate and promote the enhancement of Chinese people’s health and China’s healthcare industry. We work for meeting the diverse medical needs of China’s 1.3 billion populations in an innovative, socially responsible and commercially viable manner. We offer a broad portfolio of innovative medicines, actively partnering with healthcare providers, academics, and authorities to serve Chinese patients and to support the rapid development of the country’s healthcare system.